BIOLASE Technology, Inc. (Nasdaq: BLTI), a medical technology company focused on pain-free medical and dental procedures, today announced that it has signed new distribution agreements to sell its Waterlase(TM) and LaserSmile(TM) systems in the U.K., Scandinavia and Australia. The combined minimum quotas
for these new distributors totals over $7 million USD over the next two years.

Keith Bateman, Vice President of Global Sales commented, "As we had previously planned for 2002, these new distribution agreements further demonstrate our efforts to expand and grow our international sales.

Scandinavia, the U.K. and Australia are all essentially new markets for BIOLASE products. These new distribution partners are all promising companies with successful track records either in medical lasers or high-tech dental sales. We expect significant growth in international sales in 2002 and beyond based on existing partners, recruiting new partners and the enhanced ability
to provide excellent support through our new production/support facility in Germany and BIOLASE Europe GmbH."